[1]
Gottlieb, A.B., Elewski, B.E., Okun, M.M., Bagel, J., Poulin, Y., Gu, Y., Geng, Z., Williams, D.A. and Valdecantos, W.C. 2017. Adalimumab for Nail Psoriasis: Efficacy and Safety from the Open-Label Extension of a Phase-3, Randomized, Placebo-Controlled Trial. SKIN The Journal of Cutaneous Medicine. 1, 3.1 (Oct. 2017), s97. DOI:https://doi.org/10.25251/skin.1.supp.96.